Nova Hub

Nov
2020

Quarterly rpt on consolidated results for the financial period ended 30/09/2020

NOVA MSC BERHAD 25 Nov 2020

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 25 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 4,169,900 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 19 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 15,985,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 17 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 11,500,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

OTHERS Reseller Agreement between EYRIS Pte Ltd, a subsidiary of Nova MSC Berhad, and Topcon Healthcare Solutions Asia Pte Ltd

NOVA MSC BERHAD 12 Nov 2020   INTRODUCTION The Board of Directors of Nova MSC Berhad (“NOVAMSC”) is pleased to announce that the Company’s subsidiary, EYRIS Pte Ltd (“EYRIS”) has signed a Reseller Agreement (“RA”) with Topcon Healthcare Solutions Asia Pte Ltd (“Topcon”) today. The press release in respect of the above is also attached herewith for information.   INFORMATION…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 12 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 200,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

EYRIS PARTNERS TOPCON HEALTHCARE SOLUTIONS TO ROLL OUT SELENA+ IN HARMONY RS FOR 18 ASIAN COUNTRIES

Singapore (9 Nov, 2020) – Topcon Healthcare Solutions Asia Pacific, the leading Japanese ophthalmic solution provider, has inked an agreement with Singapore based EyRIS Private Limited to bring EyRIS SELENA+ to Harmony’s users in 18 countries in South and South East Asia. SELENA+ is a deep learning system (DLS) that can detect 3 eye diseases – diabetic retinopathy, glaucoma suspect…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 04 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 350,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Nov
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 02 Nov 2020 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 1,390,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$) (if…

Read more

Oct
2020

SELENA+ RECEIVES REGULATORY APPROVAL IN BRAZIL

Oct 2020 – SELENA+ received regulatory approval for commercialisation from ANVISA (Agência Nacional de Vigilância Sanitária) or the National Health Surveillance Agency. ANVISA is the regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices in Brazil. Brazil is one of the 20 countries of the International Diabetes Federation (IDF)…

Read more

Oct
2020

EYRIS NAMED IN “50 INNOVATIVE COMPANIES TO WATCH 2020” LIST

Oct 2020 – EyRIS was named on the list “50 INNOVATIVE COMPANIES TO WATCH 2020” compiled by The Silicon Review. The list recognizes companies that have come up with transformative innovations that deliver a fundamental shift to a new way of doing things. EyRIS stands out amongst AI companies in the healthcare sector for developing SELENA+, an AI Deep Learning…

Read more

Oct
2020

Additional Listing Announcement /Subdivision of Shares

NOVA MSC BERHAD 27 Oct 2020   1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 12,500,000 Issue price per share ($$) Malaysian Ringgit (MYR)   0.0400 Par Value($$)…

Read more